Leishmania (Leishmania) amazonensis is an important etiological agent of American
cutaneous leishmaniasis (ACL) in Brazil. The species causes a large spectrum of clinical …

Introduction Cutaneous, muco-cutaneous and visceral leishmaniasis occur due to an
infection with the protozoan parasite Leishmania. The current therapeutic options are limited …

Leishmania infantum causes visceral leishmaniasis, a deadly vector-borne disease
introduced to the Americas during the colonial era. This non-native trypanosomatid parasite …

The Leishmania donovani species complex is the causative agent of visceral leishmaniasis,
which cause 20–40,000 fatalities a year. Here, we conduct a screen for balancing selection …

Leishmania infantum is the main causative agent responsible for visceral leishmaniasis
(VL), a disease with global distribution. The genomic structure and genetic variation of this …

Background Several infectious diseases are associated with hypothalamic-pituitary-adrenal
(HPA) axis disorders by elevating circulating glucocorticoids (GCs), which are known to …

Visceral leishmaniasis (VL) is a neglected tropical disease associated with poverty and is
endemic in 56 countries worldwide. Brazil, Venezuela, and Colombia are the most affected …

Although several studies have investigated genetic diversity of Leishmania infantum in North
Africa, genome-wide analyses are lacking. Here, we conducted comparative analyses of …

Species of the genus Leishmania (Trypanosomatidae) are parasitic protists that are
transmitted to vertebrates by the bites of female sandflies (Phlebotominae) and are the …

Visceral leishmaniasis (VL) occurs due to the evolution, virulence, and adaptation of
Leishmania, vector biology, host immune system evasion, and reservoir hosts. Parasitemia …